raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:785

Estrogen resistance syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent
Status
active

Estrogen resistance syndrome is a rare, genetic endocrine disease characterized by estrogen-receptor insensitivity to estrogens and the presence of elevated estrogen and gonadotropin serum levels. Clinical manifestations include absent breast development and primary amenorrhea in association with multicystic ovaries and/or hypoplastic uterus in female patients, normal or abnormal gonadal development in male patients and markedly delayed bone maturation, persistence of open epiphyses, reduced bone mineral density, and variable tall stature in both sexes. Glucose intolerance, hyperinsulinemia and lipid abnormalities may also be present.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enEstrogen resistance syndrome
frSyndrome de résistance aux récepteurs des oestrogènes
deÖstrogen-Resistenz-Syndrom
esSíndrome de resistencia a estrógenos
itSindrome da resistenza agli estrogeni
nlOestrogeenresistentiesyndroom
ptSíndrome resistência aos estrogéneos
plZespół niewrażliwości na estrogeny
csSyndrom rezistence na estrogen
ukСиндром резистентності до естрогенів
zh雌激素抵抗综合征
trÖstrojen direnci sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM615363Evalidated
ICD-10E34.8NTBTattributedvalidated
ICD-115A90Especificvalidated
MONDO0014148Evalidated
UMLSC4510972Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (6):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ESR1Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:3467ENSG000000918311334306q25.1-q25.2estrogen receptor 18090165[PMID]_23841731[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families2 casesWorldwideCase(s)Validated8090165[PMID]_23841731[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_8090165[PMID]_23841731[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

24 annotations · validated 2016-11-23
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0003117Abnormality of circulating hormone level
HP:0008197Absence of pubertal development
HP:0008187Absence of secondary sex characteristics
HP:0003187Breast hypoplasia
HP:0002663Delayed epiphyseal ossification
HP:0008675Enlarged polycystic ovaries
HP:0000013Hypoplasia of the uterus
HP:0000837Increased circulating gonadotropin level
HP:0003799Marked delay in bone age
HP:0000938Osteopenia
HP:0000939Osteoporosis
HP:0001548Overgrowth
HP:0000786Primary amenorrhea
HP:0000098Tall stature
Frequent (79-30%)
HP:0000956Acanthosis nigricans
HP:0001061Acne
HP:0001677Coronaryartery atherosclerosis
HP:0010679Elevated tissue non-specific alkaline phosphatase
HP:0002574Episodic abdominal pain
HP:0001952Glucose intolerance
HP:0000842Hyperinsulinemia
Excluded (0%)
HP:0030087Abnormal testosterone level
HP:0000834Abnormality of the adrenal glands
HP:0100133Abnormality of the pubic hair

Run the differential on the 12 obligate / very frequent terms

Annotation source: 27754803[PMID]_24152274[PMID]_8090165[PMID]_9396482[PMID]

7

Sources for this card